Genetic Signatures

Genetic Signatures Limited – Annual Report 2021 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 30 JUNE 2021 33 Note 9: Inventory Consolidated 2021 2020 $’000s $’000s Raw materials 6,681 2,423 Work in progress 737 170 Finished goods 4,963 2,911 Stock in transit 23 1,748 Provision for obsolescence (270) - 12,134 7,252 Note 10: Government grant receivable Consolidated 2021 2020 $’000s $’000s Research & Development tax concession - 2,554 Note 11: Property, plant and equipment Consolidated 2021 2020 $’000s $’000s Plant and equipment: At cost 9,539 5,661 Less: accumulated depreciation (3,880) (2,986) 5,659 2,675 Movement in plant and equipment is as follows: Plant & equipment $’000s Total $’000s Cost at 1 July 2019 4,019 4,019 Additions 2,275 2,275 Disposals (632) (632) Cost at 30 June 2020 5,662 5,662 Accumulated depreciation 1 July 2019 (2,646) (2,646) Depreciation expense (521) (521) Disposal of assets 180 180 Accumulated depreciation 30 June 2020 (2,987) (2,987) Carrying amount 30 June 2020 2,675 2,675 Cost at 1 July 2020 5,662 5,662 Additions 4,653 4,653 Disposals (775) (775) Cost at 30 June 2021 9,540 9,540 Accumulated depreciation 1 July 2020 (2,987) (2,987) Depreciation expense (1,025) (1,025) Disposal of assets 131 131 Accumulated depreciation 30 June 2021 (3,881) (3,881) Carrying amount 30 June 2021 5,659 5,659 Financial Report